Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 40,584 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now owns 276,054 shares […]

Related Keywords

Canada ,United States ,Craig Hallum ,Rosty Raykov ,Allspring Global Investments Holdings ,Tower Research Capital ,Fennec Pharmaceuticals Price Performance ,News Ratings For Fennec Pharmaceuticals Daily ,Nasdaq ,Institutional Trading Of Fennec Pharmaceuticals ,Fennec Pharmaceuticals ,Fennec Pharmaceuticals Inc ,Royal Bank ,Quarter For Fennec Pharmaceuticals ,Get Free Report ,Pharmaceuticals Inc ,Research Capital ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,Nasdaq Fenc ,Pufenc ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,